---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-113672"
form_type: "8-K"
ticker: "HCTI"
cik: "0001839285"
company_name: "Healthcare Triangle, Inc."
filed_at: "2025-11-21T23:59:59+00:00"
generated_at: "2026-05-16T17:42:27.112621+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Healthcare Triangle raises $6M via convertible notes with 20% OID; up to $15M total

## Summary
- Initial tranche $7.5M principal (20% OID, net $6M) to institutional investors; matures Nov 20, 2026.
- Notes convertible at greater of 80% of lowest 5-day VWAP or $0.38/share; 18% past-due interest rate.
- Second $7.5M tranche conditioned on effective resale registration; registration must be filed within 10 days.
- Stockholder approval needed for conversion shares >19.99% of outstanding; special meeting set for Nov 28, 2025.
- Placement agent RBW Capital (Dawson James) receives 8% cash fee plus $100k in legal expenses.

## SEC filing metadata
- accession: 0001213900-25-113672
- form_type: 8-K
- ticker: HCTI
- cik: 0001839285
- company_name: Healthcare Triangle, Inc.
- filed_at: 2025-11-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1839285/000121390025113672/0001213900-25-113672-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1839285/000121390025113672/ea0266767-8k_healthcare.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-113672
- JSON: https://secwatch.observer/filing/0001213900-25-113672.json
- Plain text: https://secwatch.observer/filing/0001213900-25-113672.txt

## Key facts
- Debt Financings
  Healthcare Triangle, Inc. incurred convertible notes of $7,500,000 with institutional investors at 18% per annum maturing November 20, 2026.
  - Instrument: convertible notes
  - Principal: $7,500,000
  - Counterparty: institutional investors
  - Rate: 18% per annum
  - Maturity: November 20, 2026
  - Event: incurrence
  source text: Under the Purchase Agreement, the Company has agreed to issue 20% original issue discount senior unsecured convertible promissory notes (“Notes”) in an aggregate original principal amount of up to $15,000,000, which will be convertible into shares of the Company’s common stock, par value $0.00001 per share (“Common Stock”). The closing of the first tranche was consummated on November 20, 2025, and the Company issued the initial Note for an aggregate original principal amount of $7,500,000 (the “Initial Tranche”). The Note issued in the Initial Tranche was sold to the Investors for a purchase price of $6,000,000, representing an original issue discount of twenty percent (20%), and matures on November 20, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1839285/000121390025113672/0001213900-25-113672-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.